Congratulations to Dr. Abe Lee on a $1.13M grant from the National Institutes of Health, entitled “Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy”. This project will be funded for 3 years, starting September 2022. For more information, see